Yangtze River Pharmaceuticals Group

Yangzijiang Pharmaceutical Group is a prominent private pharmaceutical conglomerate based in China, recognized as one of the largest players in the nation's healthcare sector. Established in 1971 and headquartered in Taizhou, the group specializes in the research, production, and distribution of a diverse range of products, including chemical generics, innovative small molecules, and Traditional Chinese Medicines (TCM). The company maintains a strong market presence in therapeutic areas such as oncology, cardiovascular disease, gastroenterology, and anti-infectives. With a workforce of over 15,000 employees, Yangzijiang operates numerous state-of-the-art manufacturing facilities and R&D centers across China. In recent years, the group has significantly increased its investment in innovative drug development to transition from a generic-focused business to a research-driven biopharmaceutical leader.